This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj)
Medical Information
RYBREVANT FASPRO - Dosage and administration video
For additional information, please refer to the Dosing and administration scientific response.
The following information is provided because of your specific unsolicited request and is not intended as an endorsement of any usage not contained in the Prescribing Information. For complete information, please refer to the full Prescribing Information.
The following information is provided because of your specific unsolicited request and is not intended as an endorsement of any usage not contained in the Prescribing Information. For complete information, please refer to the full Prescribing Information.
Would you like to clear and leave your conversation? Message history will be lost.